These data further confirm that targeting both GSH and TXNR antioxidant systems simultaneously can achieve synergistic cancer cell killing through increased oxidative DNA damage and formation of DNA DSBs in PCa cells. This evidence concerns the gene TXNRD1 and posterior cortical atrophy.